Compare Caesars Entertainment Inc (CZR) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Caesars Entertainment Inc vs Tenet Healthcare Corporation — how do they compare? Caesars Entertainment Inc trades at $29.61 (market cap $6.06B), while Tenet Healthcare Corporation trades at $264 (market cap $20.89B). The key difference: Tenet Healthcare Corporation is far larger — about 3.4× Caesars Entertainment Inc's market cap. Which is the better fit depends on your goals.
| CZR | THC | |
|---|---|---|
Market Cap | $6.06B | $20.89B |
Sector | Consumer Cyclical | Health |
52-Week High | $30.41 | $262.63 |
52-Week Low | $18.14 | $161.37 |
Enterprise Value | $29.95B | $31.97B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Caesars Entertainment (CZR) trades at $29.61, down 1.53% on the day, with a bearish technical signal and recent quarterly earnings misses. The company shows strong operating cash flow of $1.3 billion in 2025 but faces net losses and high debt levels. Recent news highlights a pending acquisition by Tilman Fertitta for $5.7 billion, which could reshape its future.
CZR presents a mixed outlook: low P/E and P/S ratios suggest value, but persistent losses and high leverage pose risks. The acquisition offers potential upside, yet execution and integration challenges remain. Investors should weigh the attractive valuation against fundamental weaknesses and market sentiment leaning cautious.
Tenet Healthcare (THC) trades at $260.67, up 0.28% today, with strong technical momentum including a golden cross pattern and bullish moving average alignment. The company demonstrates robust fundamentals with Q2 2026 EPS beating expectations at $6.12 versus $4.26 forecast, maintaining a three-quarter earnings beat streak. Valuation metrics remain attractive with P/E of 10.03 and EV/EBITDA of 5.73, while profitability metrics show exceptional ROE of 53.31% and net margin of 9.9%.
The investment outlook remains positive with 81% analyst buy ratings and $281.44 consensus price target representing 8% upside. Key risks include policy headwinds in ACA exchanges and hospital segment challenges, though strong ambulatory growth provides offset. The stock presents a compelling value-growth combination with momentum characteristics, supported by institutional accumulation and positive earnings revisions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Caesars Entertainment Inc
Caesars Entertainment includes around 50 domestic gaming properties across Las Vegas (50% of 2021 EBITDAR before corporate and digital expenses) and regional (63%) markets. Additionally, the company hosts managed properties and digital assets, the later of which produced material EBITDA losses in 2021. Caesars' U.S. presence roughly doubled with the 2020 acquisition by Eldorado, which built its first casino in Reno, Nevada, in 1973 and expanded its presence through prior acquisitions to over 20 properties before merging with legacy Caesars. Caesars' brands include Caesars, Harrah's, Tropicana, Bally's, Isle, and Flamingo. Also, the company owns the U.S. portion of William Hill (it plans to sell the international operation in 2022), a digital sports betting platform.
Read more on CZR →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
